background image

Paid Clinical Trials Nashville

Discover 1,158 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Nashville TN, Chicago IL, Buffalo NY, Hackensack NJ, Boston MA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting
Active & Responsive

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

for
Hypertension, Hypertension, Systolic, Hypertension, Essential
Location: Nashville TN, Lexington KY, Germantown TN, Atlanta GA,
Sponsor: Orchestra BioMed, Inc

Sex: All

Age: 18+

Code: NCT06059638

Recruiting
Active & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

for
Metastatic Breast Cancer
Location: Nashville TN, Germantown TN
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT03424005

Phase1, Phase2, Recruiting
Active & Responsive

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Nashville TN, Cincinnati OH, Fairfax VA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase1, Recruiting
Active & Responsive

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced Solid Tumor, Locally Advanced Solid Tumor,
Location: Nashville TN, Louisville KY, Cincinnati OH, Springfield IL,
Sponsor: Ascendis Pharma Oncology Division A/S

Sex: All

Age: 18+

Code: NCT05081609

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for
Solid Tumor
Location: Nashville TN, St Louis MO, Augusta GA, Detroit MI, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06384807

Phase1, Phase2, Recruiting

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma,
Location: Nashville TN, Iowa City IA, Hamilton, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Nashville TN, Cincinnati OH, St Louis MO, Columbus OH,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase1, Recruiting

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

for
Relapse Multiple Myeloma, Refractory Multiple Myeloma
Location: Nashville TN, Atlanta GA, St Louis MO, Charlotte NC,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18 - 70+

Code: NCT06171685

Phase2, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Nashville TN, Birmingham AL, Athens GA, Westwood KS,
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting